| Financial Year |
March 31 2023 |
| Monetary Funds |
1,622,448,019.11 |
| Held-for-trading Financial Assets |
955,052,985.91 |
| Notes Receivable |
304,833,047.06 |
| Accounts Receivable |
954,839,313.68 |
| Advances to Suppliers |
348,470,621.85 |
| Other Receivables |
90,593,375.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
1,200,000.00 |
| Inventories |
4,849,308,101.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
327,651,551.88 |
| Total Current Assets |
9,947,339,829.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
126,684,619.81 |
| Investment Properties |
76,985,714.11 |
| Fixed Assetes |
2,181,860,693.55 |
| Under-construction Projects |
103,847,274.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
399,495,833.23 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,447,650.99 |
| Deferred Income Tax Assets |
170,715,685.23 |
| Other Non-Current Assets |
117,958,921.22 |
| Sub-Total of Non-Current Assets |
3,763,036,320.44 |
| Total Assets |
13,710,376,149.50 |
| Short-Term Loans |
710,985,186.28 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,093,863,020.08 |
| Accounts Payable |
1,706,287,952.64 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
38,604,522.06 |
| Taxes Payable |
34,628,590.46 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
149,542,720.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,273,837.54 |
| Other Current Liabilities |
439,371,722.20 |
| Sub-Total of Current Liabilities |
7,342,469,278.08 |
| Long-term Loans |
1,032,550,866.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
21,045,686.86 |
| Deferred Income Tax Liabilities |
35,599,685.86 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,195,843,715.74 |
| Total Liabilities |
8,538,312,993.82 |
| Paid-In Capital(Or Share Stock) |
969,506,674.00 |
| Capital Surplus |
2,050,189,124.43 |
| Surplus Reserve |
331,982,973.54 |
| LESS:Treasury Stock |
91,439,200.00 |
| Undistributed Profits |
1,513,258,087.64 |
| Minority Stockholder's Interest |
299,579,791.49 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,872,483,364.19 |
| Owner's Equity（Stockholder's Equity） |
5,172,063,155.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,710,376,149.50 |
